Sequana Medical - Stock

Sequana Medical P/S 2024

Sequana Medical P/S

132.57

Ticker

SEQUA.BR

ISIN

BE0974340722

WKN

A2PD78

As of Jun 26, 2024, Sequana Medical's P/S ratio stood at 132.57, a 9.51% change from the 121.06 P/S ratio recorded in the previous year.

The Sequana Medical P/S history

Sequana Medical Aktienanalyse

What does Sequana Medical do?

Sequana Medical NV is a company specialized in the development of innovative medical devices to treat and improve patients worldwide. The company was founded in Switzerland in 2006 and is headquartered in Ghent, Belgium. Sequana Medical has two main business areas: the spinaX therapy for chronic lower back pain and the alfapump system for the treatment of ascites. The spinaX therapy is an innovative medical device that treats chronic lower back pain. It is a minimally invasive therapy in which a small device is implanted in the back to stimulate the patients using electricity. This type of therapy is widely recognized and in many cases achieves significant pain relief and improvement in quality of life. The spinaX therapy is currently available in Europe and has already achieved positive results. The second main product of Sequana Medical is the alfapump system, which was specifically developed for the treatment of ascites. Ascites is an accumulation of fluid in the abdomen that can occur due to liver diseases and other causes. The alfapump system is an innovative medical device that allows for continuous drainage of the abdomen without the need for multiple punctures of the patient. The continuous drainage of the abdominal cavity improves quality of life and can also shorten hospital stays. The alfapump system has been approved as a medical device in Europe and is currently available in several European countries. Sequana Medical has undergone excellent development in recent years. The company has successfully completed several financing rounds and is expanding its international network through partnerships with other pharmaceutical and medical companies. Currently, Sequana Medical is actively working on expanding its products and services on a global level. Overall, Sequana Medical is an innovative company specialized in the development and marketing of innovative medical devices. The spinaX therapy and the alfapump system are examples of the innovation and excellence that characterize Sequana Medical. Therefore, it can be assumed that the company will continue its success in the future and play a crucial role in the medical sector. Sequana Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Sequana Medical's P/S Ratio

Sequana Medical's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Sequana Medical's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Sequana Medical's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Sequana Medical’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Sequana Medical Stock

What is the price-to-earnings ratio of Sequana Medical?

The price-earnings ratio of Sequana Medical is currently 132.57.

How has the price-earnings ratio of Sequana Medical changed compared to last year?

The price-to-earnings ratio of Sequana Medical has increased by 9.51% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Sequana Medical high compared to other companies?

Yes, the price-to-earnings ratio of Sequana Medical is high compared to other companies.

How does an increase in the price-earnings ratio of Sequana Medical affect the company?

An increase in the price-earnings ratio of Sequana Medical would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Sequana Medical affect the company?

A decrease in the price-earnings ratio of Sequana Medical would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Sequana Medical?

Some factors that influence the price-earnings ratio of Sequana Medical are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Sequana Medical pay?

Over the past 12 months, Sequana Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sequana Medical is expected to pay a dividend of 0 EUR.

What is the dividend yield of Sequana Medical?

The current dividend yield of Sequana Medical is .

When does Sequana Medical pay dividends?

Sequana Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sequana Medical?

Sequana Medical paid dividends every year for the past 0 years.

What is the dividend of Sequana Medical?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sequana Medical located?

Sequana Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sequana Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sequana Medical from 6/26/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Sequana Medical pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Sequana Medical in the year 2023?

In the year 2023, Sequana Medical distributed 0 EUR as dividends.

In which currency does Sequana Medical pay out the dividend?

The dividends of Sequana Medical are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sequana Medical

Our stock analysis for Sequana Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sequana Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.